Taken together, these data demonstrate that although combining TGFβ inhibition with sub-ablative dosing of radiotherapy does not significantly affect primary tumor growth, TGFβ inhibition significantly reduces tumor metastatic potential during radiotherapy, and downregulation of pro-metastatic ECM genes may play a role in this effect of TGFβ. Here, TGFB1 is linked to neoplasm.